Influenza A(H7N9): From anxiety to preparedness

Annals of Internal Medicine

Volumn 159, Issue 3, 2013, Pages 219-220

  Pavia, Andrew T ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; PERAMIVIR; RECOMBINANT PROTEIN; SIALIC ACID; SIALIDASE; VACCINE; ZANAMIVIR;

ANXIETY; ARTICLE; BINDING SITE; CELL CULTURE; CLINICAL STUDY; GENE EXPRESSION SYSTEM; GENE SEQUENCE; HEALTH CARE SYSTEM; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A(H7N9); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MOLECULAR DIAGNOSIS; MORTALITY; MUTATION; PANDEMIC; PANDEMIC INFLUENZA; PATHOGENICITY; PRIORITY JOURNAL; PUBLIC HEALTH; RECEPTOR BINDING; VIRUS TRANSMISSION; VIRUS VIRULENCE; ZOONOSIS;

EID: 84881145706     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-159-3-201308060-00653     Document Type: Article

References (10)

1. World Health Organization. Human infection with influenza A(H7N9) virus in China. 1 April 2013. Accessed at www.who.int/csr/don/2013_04_01/en/index.html on 27 April 2013.
2. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013.
3. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, et al. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 2013;18.
4. Pavia AT. Laboratory creation of a highly transmissible H5N1 influenza virus: balancing substantial risks and real benefits. Ann Intern Med. 2012;156:463-5.
5. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012;336:1534-41.
6. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012;486:420-8.
7. Infectious Diseases Society of America. Pandemic and Seasonal Influenza: Principles for United States Action. Arlington, VA: Infectious Diseases Society of America; 2012.
8. Couch RB, Decker WK, Utama B, Atmar RL, Niño D, Feng JQ, et al. Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans. PLoS One. 2012;7:e50830.
9. McKimm-Breschkin JL. Resistance of influenza viruses to neuraminidase inhibitors-a review. Antiviral Res. 2000;47:1-17.
10. Ison MG. Expanding the armamentarium against respiratory viral infections: DAS181 [Editorial]. J Infect Dis. 2012;206:1806-8.